Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:13 PM
Ignite Modification Date:
2025-12-24 @ 5:13 PM
NCT ID:
NCT03989050
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent form
* Age ≥18 years
* Receiving pneumococcal vaccination for the first time along STIKO criteria
* Therapy with a PD-1, anti-PD-Ligand 1 (PD-L1) agentfor melanoma, NSCLC or other malignancy
Exclusion Criteria:
* Patients unwilling/ineligible for vaccination under current STIKO recommendations
* Previous vaccination with any licensed or experimental pneumococcal vaccine
* Concurrent treatment with anti-CTLA-4 agent
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03989050
Study Brief:
Protocol Section:
NCT03989050